Loading organizations...
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| May 13, 2024 | Ajax Therapeutics | $95.0M Series C | Ming Cheah | Boxer Capital, EcoR1 Capital, Eli Lilly and Company, Point72, RA Capital Management, Schr"dinger, Vivo Capital |
| Jun 1, 2021 | Ajax Therapeutics | $40.0M Other Equity | Scott Platshon | Boxer Capital, Martin Vogelbaum, Ross Levine, NYU Langone Health, Ramy Farid |